SiRNA RSS

Filtered By:
Specialty: Internal Medicine
Source: Clinical and Translational Medicine

Filter By:
Specialty
Source
Condition
Cancer
Infectious Disease
Drug
Training
Management
Procedure
Therapy
Vaccine
Nutrition
Country

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma
Conclusions: These preclinical studies suggest that targeting p53 through PLK-1 is an attractive chemotherapy strategy warranting further investigation in adrenocortical cancer.
Source: Clinical and Translational Medicine - January 11, 2016 Category: Internal Medicine Authors: Kimberly BusseyAditi BapatClaire LinnehanMelissa WandoloskiErica DastrupErik RogersPaul GonzalesMichael Demeure Source Type: research